Filing Flows › Orthofix Medical (OFIX) › Q2 FY26
Orthofix Medical (OFIX) Q2 FY26 earnings results (second quarter fiscal 2026)
10-Q filed Aug 5, 2026
Orthofix Medical (OFIX) reported revenue of $211M for the second quarter fiscal 2026 (Q2 FY26), +4% from a year earlier and +7% from the quarter before. Operating margin was -3.9%, net loss $15.8M (7.5% of revenue).
Orthofix Medical, Q2 FY26: revenue $211M (+4% year over year), operating margin -3.9%, net loss $15.8M, operating cash flow −$6.2M. The chart follows the revenue to costs, profit and cash.
| Q2 FY26 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $211M | +7% | +4% |
| Operating profit | −$8.1M | — | — |
| Net earnings | −$15.8M | — | — |
| Operating cash flow | −$6.2M | — | -153% |
What changed
Revenue was $210.9M in Q2 FY26, up 4% year over year and up 7% from the previous quarter. Global Spine was the largest line at 82% of revenue. Global Limb Reconstruction added $4.4M year over year (up 13%), 56% of the total change.
Gross margin was 71.0%, up 2.3 points from Q2 FY25. Operating costs exceeded revenue by $8.1M, an operating margin of -3.9%. Operating expenses grew 1% against revenue growth of 4%. The fastest-growing cost line was Other operating costs (+24%). The quarter ended with a net loss of $15.8M, narrower than the previous quarter's $20.9M loss.
Operating cash flow was −$6.2M. Non-cash charges added back $13.3M of depreciation and amortization and $7.7M of share-based compensation. Working capital and other items used $11.4M. Capital expenditures of $12.6M exceeded it, leaving free cash flow of −$18.9M.
Questions
What was Orthofix Medical's revenue in the second quarter fiscal 2026?
Orthofix Medical (OFIX) reported revenue of $211M for the second quarter fiscal 2026 (Q2 FY26), +4% from a year earlier and +7% from the quarter before.
Was Orthofix Medical profitable in the second quarter fiscal 2026?
Operating loss was $8.1M (-3.9% of revenue) and net loss $15.8M.
Source: Orthofix Medical 10-Q on SEC EDGAR.